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HPV Knowledge Quiz
TRUE OR FALSE?
1. HPV is a "women's disease.”
2. Men can receive the HPV vaccine.
3. HPV infection can lead to genital warts.
4. HPV can lead to cancers of the genitals, anus,
mouth, and throat.
5. Men who have sex with men are at higher risk for
developing an HPV-related cancer.
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Answers……
•

HPV is a women’s disease. FALSE.
– Both men and women can be infected with HPV
and both can develop HPV-related cancers.

•

Men can receive the HPV vaccine. TRUE.
– The HPV vaccine was approved for use
among men in 2009.

•

HPV infection can lead to genital warts.
TRUE.
– HPV infection can lead to genital warts.
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Answers……
•

HPV can lead to cancers of the genitals,
anus, mouth, and throat. TRUE.
– HPV can lead to cervical, vulvar, penile, anal,
mouth, and throat cancers, among others….

•

Men who have sex with men are at higher
risk for developing an HPV related cancer.
TRUE.
•

In the United States, rates of anal cancer
among MSM are higher than rates of cervical
cancer among women.*
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HPV 101
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HPV 101: Basics
• Most common STI in the US: At least 50%
of sexually active men and women acquire
genital HPV infection.
• Most people do not develop health
problems from HPV (virus clears on its
own).
• Low-risk vs. high-risk types.
• Genital warts and genital cancers.
6/22/2012
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HPV 101: Screening
• No approved test for men.
• Women advised to get regular PAP tests
(and HPV DNA test) for cervical cancer
prevention.
• Some providers suggest yearly anal PAPs
for gay/bisexual men and HIV+ men.
• Genital warts diagnosed by visual exam.
6/22/2012
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HPV 101: Transmission and
Prevention
• Genital (skin-to-skin) contact; vaginal or
anal sex.
• Symptoms need not be present for
transmission.
• Condoms lower risk of transmission.
• More partners=more exposure=more risk.
• Vaccination is safe and effective
prevention for men and women.
6/22/2012
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October 2009: GARDASIL®
approved for genital wart prevention
in boys and men

6/22/2012
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Dec. 12, 2010:GARDASIL® approved
for prevention of anal cancer.
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GARDASIL®
• Licensed by Merck & Co.
• 2006 FDA approval for prevention of
cervical cancer and genital warts (females).
• Quadrivalent vaccine protective against
types 6,11,16, and 18.
• 3 dose regimen over 6 months.
• Approved for men and women aged 9-26
years.
6/22/2012
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GARDASIL®
• ACIP universal recommendation for
females (and covered by most insurance);
“permissive” recommendation for males.
• Out-of-pocket cost about $400.
• Risk higher for gay/bi men and HIV+ men,
current debate about future indication:
universal vaccination for all boys or
targeted vaccination based on risk factors*.
•

* Kim, JJ. Focus on Research: Weighing the Benefits and Costs of HPV
Vaccination of Young Men. NEJM. Feb 3, 2011; 364(5): 393-5.
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Acceptability of the HPV vaccine
among Men: Research Findings
• A 2010 literature review indicated that 74% - 78% of college men reported
they were willing to get the HPV vaccine, compared to 33% of men in a
community sample.1
• In a 2010 national study, 39% of heterosexual men had never heard of
HPV, 42% had heard of it, but had low knowledge scores, and 37% were
willing to be vaccinated (after learning of the availability of the vaccine).2
• In a similar 2010 national study among gay and bisexual men, HPVrelated knowledge and acceptability were higher; 73% had heard of
the vaccine and 74% were willing to get it.3
1 Liddon, N., Hood, J., Wynn, B. A., & Markowitz, L. E. (2010). Acceptability of human papillomavirus vaccine for males: A review of the literature.
Journal of Adolescent Health, 46(2), 113-123. doi:10.1016/j.jadohealth.2009.11.199
2 Reiter, P. L., Brewer, N. T., & Smith, J. S. (2010). Human papillomavirus knowledge and vaccine acceptability among a national sample of
heterosexual men. Sexually Transmitted Infections, 86(3), 241-246.
3 Reiter, P. L., Brewer, N. T., McRee, A. L., Gilbert, P., & Smith, J. S. (2010). Acceptability of HPV vaccine among a national sample of gay and
bisexual men. Sexually Transmitted Diseases, 37(3), 197-203.
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Rates of HPV infection
• Rates of HPV infection among men and
women are similar*
• At least 50% of sexually active men and
women will be infected with HPV in their
lives
– The MAJORITY of sexually active college
students become infected with HPV
– Multiple “type” HPV infection is not
uncommon
6/22/2012

Giuliano, A. R., Lee, J. H., Fulp, W., Villa, L. L., Lazcano, E., Papenfuss, M. R., . . . Smith,
D. (2011). Incidence and clearance of genital human papillomavirus infection in men
14
(HIM): A cohort study. Lancet, 377(9769), 932-940.

HPV-related cancers in the United
States 1998 – 2003
female, cervical

male, non-cervical

female, non-cervical

21%
(4,128)

24%
(4,753)

55%
(4,128)

Data from: Chaturvedi, A. K. (2010). Beyond cervical cancer: Burden of other HPVrelated cancers among men and women. The Journal of Adolescent Health : Official
Publication of the Society for Adolescent Medicine, 46(4)
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HPV-related cancers
• 4% of all cancers are related to HPV1
• Risk factors for HPV infection include higher number
of lifetime sex partners, infrequent condom use, and
smoking
• Anal HPV infection has been called “nearly
universal” among gay and bisexual men who are 17
times more likely to develop anal cancer2
1. Stanley, M. (2010). Pathology and epidemiology of HPV infection in females. Gynecologic
Oncology, 117(2) Suppl, S5-10.
2. Vajdic, C. M., van Leeuwen, M. T., Jin, F., Prestage, G., Medley, G., Hillman, R. J., Stevens, M.
P., Botes, L. P., Zablotska, I., Tabrizi, S. N., & Grulich, A. E. (2009). Anal human
papillomavirus genotype diversity and co-infection in a community-based sample of
homosexual men. Sexually Transmitted Infections, 85(5), 330-335.
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Rates of HPV vaccination
• Rates of HPV vaccination among men are
currently unknown, but are assumed to be
low
• Rates of HPV vaccination among women
vary between 12% and 44%
– RI has one of the highest HPV vaccination
rates
– Vaccination rates are higher among college
students
6/22/2012
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Genital Warts …..
• 6 million cases are diagnosed annually
• The CDC estimates that 1% of the
population has genital warts
• 5.6% of 18-to 59-year olds reported having
ever been diagnosed with genital warts*

6/22/2012

Dinh, T. H., Sternberg, M., Dunne, E. F., & Markowitz, L. E. (2008). Genital warts among
18- to 59-year-olds in the united states, national health and nutrition examination
survey, 1999--2004. Sexually Transmitted Diseases, 35(4), 357-360.
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HPV-related research on
campus
• Women: Research ongoing since 2009,
funded by Merck & Co.
– Aim 1: To develop measures of readiness to
receive the HPV vaccine using the Transtheoretical
Model of Change framework. DONE
– Aim 2: To develop a computer-tailored intervention
(CTI) to increase HPV vaccination. DONE
– Aim 3: To assess the feasibility, acceptability and
initial efficacy of the CTI. ONGOING
6/22/2012
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HPV-related research on
campus
• Men: Dissertation research, Spring 2011,
EGRA funding received
– Aim 1: To develop measures of readiness to
receive the HPV vaccine using the Transtheoretical
Model of Change as a framework.
– Aim 2: To examine HPV-related knowledge,
Descriptive norms, Perceived Risk, and vaccine
mistrust among men AND women.
– Aim 3: To compare men and women across all
constructs measured
6/22/2012
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Study Recruitment
• Paid Research Opportunity Available:
– See flyers

– Interested students can contact Anne
• annefernandez@gmail.com
• (401) 874-9137

6/22/2012
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HIV Prevention Study for Gay
and Bisexual Men
•

New HIV Prevention Study for Men
Dr. Michelle Lally is recruiting participants for a new Internet-based research study. We’re
interested in learning more about what gay and bisexual men think of the pros and cons of
condoms, as well as situations that may make it tempting to have unprotected sex.

•

You may be eligible to participate in a brief, confidential online survey if: you’re male, HIVnegative, between the ages of 18 and 50, have had 2 or more male sexual partners in the past
year, and have access to a computer.

•
•

If you’re interested in learning more about the study, click on this link:
http://www.zoomerang.com/Survey/WEB22BJ3ADD7UV/

•

The survey takes about 30 minutes to complete. For each completed survey received, Dr. Lally
will offer to donate $10 to Youth Pride, Inc to help support programs for GLBTQ youth in Rhode
Island.
For more information, you can go to the link or call the principal investigator, Dr. Michelle Lally
at 401-793-4770.

•
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Conclusions/Questions?
• Copies of these slides available upon
request

annefernandez@gmail.com
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